Global Vitamin D Testing Market 2015-2019

Global Vitamin D Testing Market 2015-2019

About Vitamin D Testing
Vitamin D is a naturally occurring, fat-soluble, biologically inert hormone precursor that exists in two primary forms: vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). Its main biologic function is to maintain calcium and phosphorus concentrations as it is essential for the overall bone health. Vitamin D has a number of other physiological roles, including retaining muscle strength, moderating immune function, regulating cellular differentiation, and reducing inflammation. Vitamin D test, also called 25-Hydroxy test, is used to measure the amount of vitamin in the bloodstream to rule out vitamin D deficiency. It can help determine the bone weakness, bone malformation, or abnormal metabolism of calcium (reflected by abnormal calcium, phosphorus, and PTH levels) as a result of a deficiency or excess of vitamin D.

Technavio’s analysts forecast the global vitamin D testing market to grow at a CAGR of 7.57% during the period 2014-2019.

Covered in this Report
The report covers the present scenario and the growth prospects of the global vitamin D testing market for the period 2015-2019. To calculate the market size, the report considers revenue generated through vitamin D tests.

Technavio's report, Global Vitamin D Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, APAC, and EMEA; it also covers the market landscape and its growth prospects over the coming years.
The report includes a discussion of the key vendors operating in this market.

Key Geographies
- Americas
- APAC
- EMEA

Key Vendors
- Abbott
- BioMerieux
- Diasorin
- F. Hoffmann-La Roche
- Siemens

Other Prominent Vendors
- DIAsource ImmunoAssays
- Gold Standard Diagnostics
- Immunodiagnostic Systems Holdings
- Ortho Clinical Diagnostics Inc.
- Qualigen
- Quest Diagnostics
- Tosoh Bioscience

Market Driver
- Ageing Population and Chronic Diseases
- For a full, detailed list, view our report

Market Challenger
- Declining Prices in Developed Countries
- For a full, detailed list, view our report

Market Trend
- Introduction of Novel Technology
- For a full, detailed list, view our report

Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Type of Test
07.1.1 25-Hydroxy Vitamin D Test
07.1.2 1,25-Hydroxy Vitamin D Test
08. Market Segmentation by Type of Method
08.1.1 Immunoassays
08.1.2 Direct Detection Methods
09. Market Segmentation by End-user
09.1 Global Vitamin D Testing Market by End-user
10. Geographical Segmentation
10.1 Global Vitamin D Testing Market by Geographical Segmentation 2014-2019
10.2 Vitamin D Testing Market in Americas
10.2.1 Market Size and Forecast
10.3 Vitamin D Testing Market in EMEA
10.3.1 Market Size and Forecast
10.4 Vitamin D Testing Market in APAC
10.4.1 Market Size and Forecast
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2014
18.3 Other Prominent Vendors
19. Key Vendor Analysis
19.1 Abbott Diagnostics
19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Geographical Presence
19.1.4 SWOT Analysis
19.2 DiaSorin
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Business Segmentation by Revenue 2013
19.2.4 Business Segmentation by Revenue 2012 and 2013
19.2.5 Geographical Segmentation by Revenue 2013
19.2.6 Business Strategy
19.2.7 Recent Developments
19.2.8 SWOT Analysis
19.3 bioMeriux
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Business Segmentation by Revenue 2013
19.3.4 Geographical Segmentation by Revenue 2013
19.3.5 Business Strategy
19.3.6 Recent Developments
19.3.7 SWOT Analysis
19.4 Siemens Healthcare Diagnostics
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 SWOT Analysis
19.5 Roche Diagnostics
19.5.1 Key Facts
19.5.2 Business Overview
19.5.3 Business Segmentation by Revenue 2014
19.5.4 Business Segmentation by Revenue 2013 and 2014
19.5.5 Geographical Segmentation by Revenue 2014
19.5.6 Business Strategy
19.5.7 Recent Developments
19.5.8 SWOT Analysis
20. Other Reports in this Series


List of Exhibits

Exhibit 1: Market Research Methodology
Exhibit 2: Global Vitamin D Testing Market 2015-2019 ($ millions)
Exhibit 3: Consequences of Vitamin D Deficiency
Exhibit 4: Global Guidelines for Vitamin D Test Range
Exhibit 5: Recommended Daily Intakes of Vitamin D for Global Population
Exhibit 6: Upper Limits of Vitamin D Intakes for Global Population
Exhibit 7: Segmentation of Global Vitamin D Testing Market by Type of Test
Exhibit 8: Segmentation of Global Vitamin D Testing Market by Type
Exhibit 9: Segmentation of Global Vitamin D Testing Market by Type of Method
Exhibit 10: Segmentation of Global Vitamin D Testing Market by End-user
Exhibit 11: Segmentation of Global Vitamin D Testing Market by End-user 2014
Exhibit 12: Vitamin D Market in Americas 2014-2019 ($ millions)
Exhibit 13: Vitamin D Market in US by Volume 2014-2019 (million units)
Exhibit 14: Vitamin D Market in EMEA by Revenue 2014-2019 ($ millions)
Exhibit 15: Vitamin D Market in EMEA by Volume 2014-2019 (million units)
Exhibit 16: Vitamin D Market in APAC by Revenue 2014-2019 ($ millions)
Exhibit 17: Abbott Diagnostics: Key Takeaways
Exhibit 18: bioMérieux: Key Takeaways
Exhibit 19: DiaSorin: Key Takeaways
Exhibit 20: Siemens: Key Takeaways
Exhibit 21: Roche Diagnostics: Key Takeaways
Exhibit 22: Abbott Diagnostics: Geographical Presence
Exhibit 23: DiaSorin: Business Segmentation by Revenue 2013
Exhibit 24: DiaSorin: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 25: DiaSorin: Geographical Segmentation by Revenue 2013
Exhibit 26: bioMeriux: Business Segmentation by Revenue 2013
Exhibit 27: bioMeriux: Geographical Segmentation by Revenue 2013
Exhibit 28: Roche Diagnostics: Business Segmentation by Revenue 2014
Exhibit 29: Roche Diagnostics: Business Segmentation by Revenue 2013 and 2014 ($ billion)
Exhibit 30: Roche Diagnostics: Geographical Segmentation by Revenue 2014
Loading...

We are very sorry, but an error occurred.
Please contact support@reportbuyer.com if the problem remains.

Looking for something else?